Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.98 is 48% below its 5-year average of 15.42, near the low end of its 5-year range (7.98–31.66).
As of the fiscal period ended Tuesday, June 30, 2026. 38.16% below its 12-month average of 12.91.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.98.
QUICK RATIO (ACID-TEST)
7.98
QUICK RATIO (ACID-TEST) AVG TTM
12.91
QUICK RATIO (ACID-TEST) AVG 3Y
13.45
QUICK RATIO (ACID-TEST) AVG 5Y
15.42
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-38.16%
CURRENT VS 3Y AVG
-40.65%
CURRENT VS 5Y AVG
-48.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 734 covered companies
CURRENT VS SECTOR MEDIAN
+150.19%
vs the sector median at left
Nkarta, Inc.
Market Cap
$173.38M
Quick Ratio (Acid-Test)
7.98
TTM Avg
12.91
3Y Avg
13.45
5Y Avg
15.42
Market Cap
$173.79M
Quick Ratio (Acid-Test)
1.25
TTM Avg
2.29
3Y Avg
3.57
5Y Avg
4.16
Market Cap
$173.98M
Quick Ratio (Acid-Test)
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$173.23M
Quick Ratio (Acid-Test)
3.49
TTM Avg
3.52
3Y Avg
4.49
5Y Avg
5.44
Market Cap
$176.36M
Quick Ratio (Acid-Test)
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
Market Cap
$171.62M
Quick Ratio (Acid-Test)
2.09
TTM Avg
2.02
3Y Avg
3.00
5Y Avg
2.71
Market Cap
$169.85M
Quick Ratio (Acid-Test)
3.00
TTM Avg
3.33
3Y Avg
2.94
5Y Avg
2.72
Market Cap
$178.44M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.25
3Y Avg
1.14
5Y Avg
1.20
Market Cap
$165.58M
Quick Ratio (Acid-Test)
5.58
TTM Avg
2.96
3Y Avg
5.18
5Y Avg
6.05
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $173.38M | 7.98 | 12.91 | 13.45 | 15.42 |
| Cue Biopharma, Inc. (CUE)vs › | $173.79M | 1.25 | 2.29 | 3.57 | 4.16 |
| Precision BioSciences, Inc. (DTIL)vs › | $173.98M | 12.82 | 9.83 | 6.43 | 5.45 |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | 3.49 | 3.52 | 4.49 | 5.44 |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.36M | 11.22 | 14.99 | 15.44 | 13.43 |
| MediWound Ltd. (MDWD)vs › | $171.62M | 2.09 | 2.02 | 3.00 | 2.71 |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | 3.00 | 3.33 | 2.94 | 2.72 |
| Journey Medical Corporation (DERM)vs › | $178.44M | 1.41 | 1.25 | 1.14 | 1.20 |
| OptimizeRx Corp. (OPRX)vs › | $165.58M | 5.58 | 2.96 | 5.18 | 6.05 |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.12M | 4.98 | 16.09 | 15.64 | 15.37 |
Quick Ratio
7.98
Excludes inventory
Current Ratio
7.98
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.98 |
| 2026-03-31 | 12.96 |
| 2025-12-31 | 12.69 |
| 2025-09-30 | 15.23 |
| 2025-06-30 | 15.67 |
| 2025-03-31 | 14.48 |
| 2024-12-31 | 14.45 |
| 2024-09-30 | 12.91 |
| 2024-06-30 | 15.91 |
| 2024-03-31 | 19.95 |
| 2023-12-31 | 10.85 |
| 2023-09-30 | 10.97 |
| 2023-06-30 | 10.77 |
| 2023-03-31 | 12.79 |
| 2022-12-31 | 16.36 |
| 2022-09-30 | 15.17 |
| 2022-06-30 | 31.66 |
| 2022-03-31 | 20.59 |
| 2021-12-31 | 18.99 |
| 2021-09-30 | 21.96 |
| 2021-06-30 | 27.68 |
| 2021-03-31 | 32.31 |
| 2020-12-31 | 36.10 |
| 2020-09-30 | 34.88 |
| 2020-06-30 | 0.37 |
| 2020-03-31 | 2.83 |
| 2019-12-31 | 4.56 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
